Latest news and articles about علاج السرطان from NEX English
Eli Lilly has announced its acquisition of Calyonia Pharmaceuticals in a deal valued at $7 billion. The agreement includes an upfront payment of $3.25 billion, with additional payments contingent on achieving clinical, regulatory, and commercial milestones.
The Malaysian Deputy Health Minister, <strong>Dato Hanifah Hajar Taib</strong>, announced the establishment of the <strong>Sarawak Cancer Center</strong> in 2027, following the completion of the project design. This initiative aims to enhance cancer treatment services in Sarawak and neighboring areas.
Researchers at New York University Abu Dhabi have developed smart nanoparticles capable of detecting and treating cancer at the same time. This advancement represents a significant step forward in healthcare, reflecting scientific progress in combating incurable diseases.
A team of researchers has unveiled an innovative drug compound that helps slow the spread of colon, rectal, and liver cancer. This groundbreaking discovery could pave the way for more effective cancer treatments.
Researchers at NYU Abu Dhabi have developed smart particles with exceptional capabilities to detect and treat cancerous tumors, paving the way for more precise and safer treatments. This innovative technology represents a significant scientific achievement in cancer therapy.
KHZ Mustafa Hospital in Tasikmalaya, West Java, has announced the opening of comprehensive cancer treatment services to facilitate access for local patients. This development follows years of planning aimed at reducing the need for travel to distant hospitals.
The Russian Ministry of Health has announced the use of a vaccine specifically designed to treat melanoma skin cancer, administered to the first patient, a 60-year-old man. This development is part of Russia's efforts to address cancer treatment challenges.
Researchers at the Massey Comprehensive Cancer Center have developed a new drug aimed at preventing the spread of prostate cancer to the bones, potentially changing treatment approaches for this serious disease affecting millions of men worldwide.
In an inspiring story, an Australian named Paul Cunningham utilized artificial intelligence to create an experimental treatment for his ailing dog, Rosie, significantly improving her health. This remarkable tale has captured the attention of OpenAI CEO Sam Altman, who called it 'an amazing story.'
A recent study reveals that <strong>Telmisartan</strong>, a medication for high blood pressure, significantly enhances the effectiveness of the immunotherapy <strong>Olaparib</strong> against cancer, opening new avenues in the fight against tumors.
A recent clinical study at the cancer treatment center in Los Angeles reveals promising outcomes for recurrent prostate cancer using targeted PSMA nuclear therapy. This could revolutionize available treatment options.
Researcher Boris Gladkikh from Volgograd Technical University reveals ongoing efforts to develop new pharmaceutical compounds aimed at inhibiting the defense systems of cancer cells, making them more susceptible to traditional treatments. This innovation comes at a time when cancer cases are on the rise globally.
Researchers have made significant scientific progress in cancer treatment by utilizing CRISPR technology to inject immune cells directly into the body, potentially eliminating the need for traditional chemotherapy. This breakthrough was revealed in a study published on March 18, 2026, in the journal Nature.
Researchers at the University of Manchester have developed small, flexible robots capable of delivering cancer-fighting drugs directly to bowel tumors. This innovation marks a significant advancement in cancer treatment.
Dr. Fahd Al-Khudairi, a cancer research specialist, warns against a misleading message claiming that olive oil can effectively treat cancer. He emphasizes that this claim lacks any reliable scientific evidence.
Mercedes has announced its acquisition of Turns Pharmaceuticals for <strong>$6.7 billion</strong>, granting access to a promising treatment for <strong>blood cancer</strong>. This move comes as the company faces the expiration of a patent for one of its best-selling cancer drugs.
Mercedes, a global pharmaceutical giant, has announced its acquisition of American company Turnus Pharmaceuticals for <strong>$6.7 billion</strong>. This move aims to strengthen Mercedes' portfolio ahead of the patent expiration of its best-selling drug, Keytruda, in 2028.
Researchers from Shandong University in China have successfully developed genetically modified bacteria to treat cancerous tumors, opening new avenues in targeted therapy. The study demonstrated the effectiveness of these bacteria in delivering drugs directly to tumors.
Scientists have made significant progress in combating one of the deadliest forms of brain cancer by developing a genetically modified virus. This virus enables the immune system to precisely identify and target tumors, opening new avenues for treatment.